MKI67 and glioma: Interestingly, in addition to reducing the population of proliferating glioma cells as evident from H and E, the triple-drug combination depicted a significantly reduced angiogenesis and proliferation as evident from the IHC and qRT-PCR analysis of Ki67, VEGF and its receptor VEGFR in tumor sections (Figures 2, 3B).